Navigation Links
Premier Research Appoints Melissa Jones as Vice President, International Business Development
Date:9/11/2007

PHILADELPHIA, Sept. 11 /PRNewswire-FirstCall/ -- Premier Research Group plc (AIM: PRG) announces the appointment of Melissa Jones as Vice President, International Business Development. Ms. Jones will be responsible for leading the International Business Development group.

Ms. Jones previously held a senior business development position within Kendle International leading a Global Key Account group. She has over 11 years experience within business development in the CRO sector with such companies as Innovex, Quintiles, MDS Pharma Services, and Kendle International. Ms. Jones began her career working within data management for Innovex progressing to team management where she was also responsible for the insourcing of data managers within the pharmaceutical sector. Ms. Jones has a BSc Honors degree in Biology from the University of Portsmouth.

Commenting on Ms. Jones' appointment, Peter Malamis, President, Global Corporate Development, said, "We are delighted to be able to welcome Melissa into the organization in this important role both as a leader for our International Sales group and as a member of our senior management team. Melissa brings to the company extensive business development and management experience and will make an immediate and significant impact on the continued successful growth of the company."

About Premier Research

Premier Research is a leading solutions-driven CRO leveraging our commitment to therapeutic focus and scientific expertise to deliver clinical trial services of the highest quality for biopharmaceutical and medical device companies. They are leader in clinical research for Analgesia, CNS, Infectious Disease, and Oncology and have a wealth of experience in medical device and pediatric research. Premier Research has 29 offices and operates in more than 30 countries across Europe and North America. Premier Research employs more than 850 clinical professionals dedicated first and foremost to fulfilling each cl
'/>"/>

SOURCE Premier Research Group plc
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. The DIG System Nonradioactive Automated High-Throughput In Situ Hybridization: a Powerful Tool for Functional Genomics Research
2. Quantitation of the Protein MIA as a Marker for Chondrocytes in Research Samples
3. Control Your siRNA Research
4. Getting Started with MicroRNA Research
5. Monitoring Microbial Populations Using Real-Time qPCR on the MJ Research Opticon 2 System
6. Proteomics in Bladder Cancer Research: Protein Profiling of Bladder Squamous Cell Carcinomas, Rev C
7. Research Organics
8. A Robust LC/MS/MS Method for the Quantitation of Very Long Chain Fatty Acids for Research into the Characterization of Peroxisomal Disorders
9. A new LC/MS/MS Research Method for Rapid Quantitation of Five Immunosuppressant Drugs, including Mycophenolic Acid (MPA)
10. Research Tools for Analysis of ZAP-70
11. Technical Specifications Accelerating Your Research with the BD FACSCanto High Throughput Sampler Option
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/11/2009)... DIEGO, Dec. 11 Ambit Biosciences Corporation announced ... Texas M. D. Anderson Cancer Center of the first ... Monotherapy E fficacy) Phase 2 pivotal ... leukemia (AML). AC220 is a novel, orally available, ... designed as a FMS-like tyrosine kinase-3 (FLT3) inhibitor. ...
(Date:12/11/2009)... 11 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX:ONC, NASDAQ: ... the appointment of Dr. Alan Warrander to the ... Business Development. ,, "Dr. Warrander will be responsible ... for REOLYSIN(R)," said Dr. Brad Thompson, President and ... the design of a Phase 3 trial examining ...
(Date:12/10/2009)... 10 Endologix, Inc. (Nasdaq: ELGX ... disorders, announced today that Dan Lemaitre, former President ... Board of Directors effective December 11, 2009. ... non-independent directors. ,, Franklin D. Brown, Chairman of ... Dan Lemaitre to the Endologix Board of Directors. ...
(Date:12/10/2009)... ON, Dec. 10 /PRNewswire-FirstCall/ - YM BioSciences Inc. ... life sciences product development company that identifies and ... at various stages of development, today provided an ... in the merger of Cytopia Ltd. into YM, ... 2009. The board of directors of Cytopia has ...
Breaking Biology Technology:Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 2Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 3Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 4Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 5Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 2Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 3Endologix Appoints Dan Lemaitre to its Board of Directors 2YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 2YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 3YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 4
... the Board -, MADISON, N.J., April 24 ... Robert Essner, 60, has decided to retire,from the Company ... position,of Chairman since January 2003 and served as Wyeth,s ... of Directors has elected,Bernard Poussot, Wyeth,s President and Chief ...
... N.J., April 24 Pharmasset, Inc.,(Nasdaq: VRUS ) ... Conference being held from April 30, 2008 to May ... Schaefer Price,Pharmasset,s Chief Executive Officer, will provide an overview ... Morgan Stanley,representatives on Wednesday, April 30, 2008 at 3:40 ...
... genetics,Inc. (Nasdaq: DCGN ) today announced that it will ... to be issued on Thursday, May 1,after the close of ... live,webcast of its conference call to discuss these results and ... noon GMT/1pm,British Summer Time., The webcast can be accessed ...
Other Biology Technology:Wyeth Chairman Robert Essner Announces June 27 Retirement 2Pharmasset to Present at the Morgan Stanley Global Healthcare Conference on Wednesday, April 30th 2deCODE genetics Announces Webcast of Conference Call to Discuss First Quarter 2008 Financial Results 2
(Date:12/13/2009)... discovered five genetic variants that are associated with the ... international consortium of 96 scientists from 63 centres in ... basis of lung diseases. , The new findings provide ... Obstructive Pulmonary Disease (COPD) and asthma. In the past ... the molecular pathways that affect the health of the ...
(Date:12/11/2009)... COLLINS, COWild Malus orientalis species of wild apples ... native to the Middle East and Central Asia. A ... M. orientalis varieties from Georgia and Armenia with ... the large population and establishes a core collection that ... the breeding and research communities. , To identify and ...
(Date:12/11/2009)... CLEVELAND Case Western Reserve University has granted ... Inc. regarding a portfolio of insulin analogs. The ... exercise its option to obtain an exclusive license ... , Cleveland-based Thermalin Diabetes is developing treatments that ... the $12 billion, rapidly growing insulin market. Insulin ...
Breaking Biology News(10 mins):New genes for lung disease discovered 2Understanding apples' ancestors 2Case Western Reserve University grants option to startup Thermalin Diabetes Inc. 2Neural stem cell differentiation factor discovered 9064 1Neural stem cell differentiation factor discovered 9064 2First Human Receives Cardiac Stem Cells in Clinical Trial to Heal Damage Caused By Heart Attacks 50395 1First Human Receives Cardiac Stem Cells in Clinical Trial to Heal Damage Caused By Heart Attacks 50395 2First Human Receives Cardiac Stem Cells in Clinical Trial to Heal Damage Caused By Heart Attacks 50395 3First Human Receives Cardiac Stem Cells in Clinical Trial to Heal Damage Caused By Heart Attacks 50395 4Allegiant Professional Business Services Inc Signs New Members to Its PPO Health Insurance Plan Annual Revenues Projected to Increase by 245M 50391 1Allegiant Professional Business Services Inc Signs New Members to Its PPO Health Insurance Plan Annual Revenues Projected to Increase by 245M 50391 2
... The American Dietetic Association has released an updated ... enhanced foods can benefit a person,s health when consumed ... and urges continued efforts to educate the public on ... issue of the Journal of the American Dietetic ...
... MD, PhD is the inaugural recipient of the Richard King ... American College of Medical Genetics Foundation (ACMGF) to encourage ABMG ... quality research in Genetics in Medicine. Each year the editorial ... ABMG trainee who was either a first or corresponding author ...
... H. Holmes Pioneer Awards will be presented on April 3 ... The awards honor two recipients who have contributed to the ... will be presented to Lawrence Platt, MD, of the David ... Los Angeles, California. The basic science award will be presented ...
Other Biology News:ADA releases updated position statement on functional foods 2ADA releases updated position statement on functional foods 3Jonathan Berg, M.D., Ph.D. awarded Richard King Trainee Award for Best in Genetics in Medicine 2AIUM Presents 2009 Joseph H. Holmes Pioneer Awards 2
...
BD Falcon microtest assay plate. 1536 well 12l, black BD Optilux PS. Polystyrene, nonsterile, no lid (15/sp, 60/ca) Packaging: 15 / pack, 60 / case ...
... low background fluorescence, minimal light scatter ... medium binding) polystyrene surface is hydrophobic ... passive interactions,• Is suitable primarily ... such as antibodies, that have large ...
... Sulfo SBED Protein:Protein Interaction Reagent A ... has rapidly gained traction as an in ... growing number of publications feature the exclusive ... to study a variety of issues relating ...
Biology Products: